Mar 2023

HeartForce files new provisional patent in the US

HeartForce filed a patent application in the United States for monitoring patients after coronary angioplasty.  The provisional patent was assigned the application number U.S. 63/459960.  Meanwhile, the company will be conducting a one-year clinical study through the monitoring patients pre and post stent surgery

Back to News